pirenzepine has been researched along with Cancer of Prostate in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The microarray database of prostate cancer shows a dominant expression of CHRM1 in prostate cancer compared with other cholinergic subtypes." | 1.46 | Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer. ( Abbas, F; Ahmad, HR; Effendi, V; Khan, NA; Mannan Baig, A; Rana, Z, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mannan Baig, A | 1 |
| Khan, NA | 1 |
| Effendi, V | 1 |
| Rana, Z | 1 |
| Ahmad, HR | 1 |
| Abbas, F | 1 |
1 other study available for pirenzepine and Cancer of Prostate
| Article | Year |
|---|---|
Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Dicyclomine; Humans; Male; Pirenzepine; Prostatic Neoplasms; P | 2017 |